N-α-Z-L-lysine

N-α-Z-L-lysine is an Nα-benzyloxycarbonyl (Z, Cbz) protected L-lysine derivative in which the ε-amino side chain remains unprotected while the α-amino group is carbamate-protected, preserving the stereochemical integrity of the lysine chiral center. The molecule contains a free carboxylic acid for C-terminal reactivity and a primary amine on the side chain that can participate in nucleophilic acylation, alkylation, and coupling chemistry. The Z group provides orthogonal protection behavior under hydrogenolysis conditions, enabling selective deprotection strategies during peptide assembly or downstream derivatization. The combination of a protected α-amino functionality with a reactive ε-amine makes N-α-Z-L-lysine a practical chiral amino acid intermediate for controlled peptide building block preparation, side-chain functionalization, and subsequent synthetic elaboration.

1. Peptide Synthesis

N-α-Z-L-lysine is used in peptide coupling workflows where the Z-carbamate protects the α-amino group from premature reaction while the free ε-amine can be left available for orthogonal side-chain chemistry or further protection. The carboxylic acid enables activation for amide bond formation at the C-terminus, supporting incorporation as a lysine-containing residue in protected amino acid sequences. Hydrogenolysis of the Z group can be applied to generate a lysine derivative with an unmasked α-amino functionality for sequential coupling steps, while the ε-amine can be protected or transformed as required by the target peptide architecture. Peptide building block preparation with controlled Nα protection and lysine side-chain reactivity supports synthesis of peptidic scaffolds, protected peptide intermediates, and lysine-rich analogs for biochemical research.

2. Side-Chain Functionalization

N-α-Z-L-lysine is suitable for chemical biology and synthetic organic chemistry routes that require selective modification of the lysine ε-amino group without disturbing the Nα protection state. The free primary amine can undergo acylation to introduce reporter handles, affinity tags, or linker motifs, and can be employed for reductive amination or nucleophilic substitution-based conjugation strategies depending on the electrophile set. The Z-protected α-amino group helps maintain chemoselectivity during side-chain derivatization, allowing downstream peptide coupling after functional group installation. Functionalized lysine derivatives prepared from N-α-Z-L-lysine can serve as intermediates for bioconjugation reagents, peptidomimetic fragments, and labeled standards used in analytical and materials-oriented studies.

3. Chiral Amino Acid Intermediate

N-α-Z-L-lysine is applied as a chiral amino acid intermediate for stereochemically defined synthesis of protected lysine building blocks and downstream amino acid derivatives. The preserved L-configuration at the lysine stereocenter supports consistent stereochemical outcomes in peptide coupling chemistry and in the construction of stereodefined peptidomimetics. The orthogonal protection profile, where the Nα is masked as a Z-carbamate while the ε-amine remains reactive, enables stepwise protection/deprotection logic to match the requirements of multistep synthesis. Chiral intermediate preparation from N-α-Z-L-lysine can feed fine chemical synthesis programs that require controlled functional group timing, including C-terminal activation, Nα unmasking, and subsequent ε-amine transformation.

4. Bioconjugation Chemistry

N-α-Z-L-lysine is used in bioconjugation and biomolecule modification workflows where lysine side-chain reactivity is leveraged to install linkers, tags, or reactive moieties onto peptide or protein scaffolds. The molecule's free ε-amino group can be converted into amide, urea, or carbamate linkages, enabling attachment of functional groups that later support conjugation to biomolecular targets. Z protection of the α-amino group helps prevent unintended crosslinking during linker synthesis and can be removed when a free α-amino handle is needed for further assembly. Bioconjugation reagent and intermediate generation from N-α-Z-L-lysine supports construction of labeled peptides, affinity probes, and modular conjugates used for molecular recognition studies and analytical method development.

5. Pharmaceutical Intermediate Preparation

N-α-Z-L-lysine is relevant to pharmaceutical manufacturing and process chemistry as a lysine-based protected amino acid intermediate for controlled synthesis of peptide-like intermediates and peptidomimetic precursors. The Z-carbamate protection on the α-amino group provides a defined protection stage that can be managed in manufacturing sequences to reduce side reactions during coupling and functional group installation. The free carboxylic acid supports activation chemistry for forming amide bonds in the production of lysine-containing fragments, while the ε-amine can be protected or transformed to meet the protection pattern required by the target intermediate. Process-oriented use of N-α-Z-L-lysine supports fine chemical synthesis planning where orthogonal protection strategies and functional group timing are required for repeatable, scalable intermediate preparation.

6. Analytical Research Standards

N-α-Z-L-lysine is employed in analytical research settings as a structurally defined lysine derivative for method development, calibration, and reference material preparation. The combination of a Z-protected α-amino group and an unprotected ε-amine yields predictable ionization and derivatization behavior in chromatographic and mass spectrometric workflows when compared with fully protected or fully deprotected analogs. The compound can be used to generate derivatized standards that reflect specific protection states, enabling verification of deprotection steps, monitoring of peptide coupling intermediates, or assessment of lysine side-chain functional group transformations. Analytical research and quality control use of N-α-Z-L-lysine supports reproducible tracking of amino acid derivative chemistry across peptide synthesis and intermediate manufacturing pipelines.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function